scispace - formally typeset
F

Feng Chen

Researcher at Northwestern University

Publications -  31
Citations -  4023

Feng Chen is an academic researcher from Northwestern University. The author has contributed to research in topics: Apoptosis & Caspase. The author has an hindex of 25, co-authored 30 publications receiving 3742 citations.

Papers
More filters
Journal ArticleDOI

Caspase cleavage of tau: Linking amyloid and neurofibrillary tangles in Alzheimer's disease

TL;DR: A novel mechanism linking amyloid deposition and neurofibrillary tangles in AD is suggested: Aβ peptides promote pathological tau filament assembly in neurons by triggering caspase cleavage of tau and generating a proteolytic product with enhanced polymerization kinetics.
Journal ArticleDOI

Catechol Polymers for pH-Responsive, Targeted Drug Delivery to Cancer Cells

TL;DR: This study demonstrated that the cancer-targeting drug–polymer conjugates dramatically enhanced cellular uptake, proteasome inhibition, and cytotoxicity toward breast carcinoma cells in comparison with nontargeting drug-polymer Conjugates.
Journal ArticleDOI

The Small Heat Shock Protein αB-Crystallin Negatively Regulates Cytochrome c- and Caspase-8-dependent Activation of Caspase-3 by Inhibiting Its Autoproteolytic Maturation

TL;DR: It is demonstrated that αB-crystallin is a novel negative regulator of apoptosis that acts distally in the conserved cell death machinery by inhibiting the autocatalytic maturation of caspase-3.
Journal ArticleDOI

Caspase cleavage of vimentin disrupts intermediate filaments and promotes apoptosis.

TL;DR: It is suggested that caspase proteolysis of vimentin promotes apoptosis by dismantling intermediate filaments and by amplifying the cell death signal via a pro-apoptotic cleavage product.
Journal ArticleDOI

αB-Crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancer

TL;DR: The results indicate that alphaB-crystallin is a novel oncoprotein expressed in basal-like breast carcinomas that independently predicts shorter survival and implicate the MEK/ERK pathway as a potential therapeutic target for these tumors.